Santhera Pharmaceuticals Holding has exclusively granted the rights to commercialise its Duchenne muscular...
Up To Date
Latest News
BioSenic SA has suspended its Phase II proof-of-concept trial on fracture healing with its allogeneic cell...
Swedish personalised immunotherapy specialist Neogap Therapeutics AB has acquired the remaining shares of its...
An international research team headed by Pablo Guardado-Calvo at Institut Pasteur Paris has demonstrated...
Syncona Ltd had spun-out the ophtalmology specialist Beacon Therapeutics Holdings Ltd with a £96m Series A...
Roche AG has announced positive results from the non-blinded Phase III COMMODORE 1 and 2 trials at the EHA...